SVB Wealth LLC Makes New Investment in UiPath Inc. (NYSE:PATH)

SVB Wealth LLC purchased a new position in shares of UiPath Inc. (NYSE:PATH – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 38,736 shares of the healthcare company’s stock, valued at approximately $489,000.

A number of other institutional investors have also recently bought and sold shares of PATH. SeaCrest Wealth Management LLC acquired a new stake in UiPath during the second quarter worth $25,000. Householder Group Estate & Retirement Specialist LLC acquired a new stake in shares of UiPath in the 3rd quarter valued at $25,000. Banque Cantonale Vaudoise boosted its stake in shares of UiPath by 20,080.0% in the 2nd quarter. Banque Cantonale Vaudoise now owns 2,018 shares of the healthcare company’s stock valued at $37,000 after purchasing an additional 2,008 shares in the last quarter. CWM LLC acquired a new stake in shares of UiPath in the 2nd quarter valued at $40,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new stake in shares of UiPath in the 2nd quarter valued at $59,000. Institutional investors and hedge funds own 56.40% of the company’s stock.

Get UiPath alerts:

UiPath Trading Up 4.4 %

Shares of NYSE:PATH opened at $16.07 on Wednesday. The stock has a market capitalization of $8.88 billion, a P/E ratio of -23.98 and a beta of 0.62. UiPath Inc. has a 1-year low of $10.40 and a 1-year high of $39.00. The business has a 50-day moving average price of $13.81 and a two-hundred day moving average price of $14.21.

UiPath (NYSE:PATH – Get Rating) last announced its quarterly earnings data on Thursday, December 1st. The healthcare company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.09. The firm had revenue of $262.74 million during the quarter, compared to analysts’ expectations of $248.07 million. UiPath had a negative return on equity of 17.19% and a negative net margin of 34.99%. As a group, equities analysts predict that UiPath Inc. will post -0.55 EPS for the current year.

Insider Activity

In other news, CFO Ashim Gupta sold 10,000 shares of the company’s stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $13.50, for a total value of $135,000.00. Following the completion of the sale, the chief financial officer now directly owns 1,515,341 shares of the company’s stock, valued at approximately $20,457,103.50. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CAO Hitesh Ramani sold 2,100 shares of the company’s stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $14.45, for a total value of $30,345.00. Following the completion of the sale, the chief accounting officer now directly owns 438,452 shares of the company’s stock, valued at approximately $6,335,631.40. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Ashim Gupta sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 5th. The shares were sold at an average price of $13.50, for a total value of $135,000.00. Following the completion of the transaction, the chief financial officer now owns 1,515,341 shares of the company’s stock, valued at $20,457,103.50. The disclosure for this sale can be found here. 31.88% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on PATH. Mizuho boosted their target price on shares of UiPath from $14.00 to $15.00 in a research note on Friday, December 2nd. Royal Bank of Canada reduced their target price on shares of UiPath from $16.00 to $15.00 and set a “sector perform” rating on the stock in a research note on Monday, November 28th. Oppenheimer downgraded shares of UiPath from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 3rd. Wells Fargo & Company lifted their price target on UiPath from $16.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, December 2nd. Finally, Barclays cut their price target on UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a report on Tuesday, January 10th. Nine analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $17.97.

About UiPath

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

• Get a free copy of the StockNews.com research report on UiPath (PATH)
• LCI Industries Diversification Strategy Pays Off
• Is It Time To Buy The Dip In The Coca-Cola Company 
• Ex-Dividend Date vs. Record Date: What’s the Difference?
• How Does the Consumer Price Index Affect the Stock Market?
• Are Denny’s Corporation Investors Due For A Grand Slam?

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Get Rating).

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.